Welcome and thanks for reading!
In this review, I will make a summary of important and interesting news and events over the last week related to my portfolio holdings. Also, I will put together some interesting articles from other websites that caught my attention during the past week.
Received Dividends:
May 30, 2022
- € 13.64 – Starbucks Corporation (SBUX)
- € 16.80 – Eaton Corporation plc (ETN)
May 31, 2022
- € 540.65 – Sampo plc (SAMPO)
- € 13.13 – LTC Properties, Inc. (LTC)
June 1, 2022
- € 101.71 – Intel Corporation (INTC)
- € 7.56 – WEC Energy Group, Inc. (WEC)
- € 38.25 – Pinnacle West Capital Corporation (PNW)
- € 9.56 – ConocoPhillips (COP)
- € 2.60 – Visa Inc. (V)
- € 20.77 – Aflac Incorporated (AFL)
- € 31.28 – Magna International Inc. (MGA)
June 2, 2022
- € 8.34 – Metro Inc. (MRU)
- € 78.23 – Enbridge Inc. (ENB)
- € 41.29 – Fortis Inc. (FTS)
- € 39.18 – Canadian Utilities Limited (CU)
Week 22: Total net dividends € 962.99.
Dividend income is reported after the deduction of taxes. Check more at my Monthly Dividend sheet.
My Portfolio's Transactions:
June 3, 2022
- I purchased 50 shares of STORE Capital Corporation (STOR) at $ 27.40 per share plus commission.
At today's exchange rate that purchase 50 shares of STOR will increase € 53.52 of my expected annual net dividend income. After this acquisition, STOR’s weight of my portfolio is about 0.37% and its share of future annual dividend income is approximately 0.57%.
Portfolio Holdings News:
May 30, 2022
- Unilever plc (AMS:UNA) to acquire majority stake in Nutrafol; UNA announced that it has signed an agreement to acquire a majority stake in Nutrafol, a leading provider of hair wellness products. Unilever currently holds a minority stake (13.2%) in Nutrafol through Unilever Ventures.
May 31, 2022
- Telia Company (TELIA) completes the sale of Telia Latvia to Tet; TELIA completed the sale of 100 percent of the shares in Telia Latvija SIA (“Telia Latvia”) to Tet SIA (“Tet”) at a price corresponding to an enterprise value of EUR 10.75 million on a cash and debt free basis, as all regulatory approvals have been received. The price represents a FY 2021 EV/EBITDA multiple of 10x. The agreement to sell Telia Latvia to Tet was announced on January 4, 2022.
June 1, 2022
- Telia Company (TELIA) completes the sale of a minority stake in its Swedish tower business to Brookfield and Alecta; TELIA completed the divestment of 49 percent of its tower business in Sweden, to Brookfield and Alecta, as all regulatory approvals have been received.
- Telia Company initiates previously announced share buy-back program; TELIA announces that the Board of Directors has decided to initiate a share buy-back program for a total amount of SEK 5.4 billion. The decision comes after the closing of the Swedish tower transaction and the previously communicated intention to buy back shares, as announced in connection with Telia Company’s interim report January-March 2022 on April 27, 2022.
- Pfizer Inc. (PFE) Update on Ownership Interest in Haleon; PFE intends to exit its 32% stake in Haleon, GSK's (GSK) consumer healthcare business which is headed for a spinoff in July.
- Medifast, Inc. (MED) Announces $100M Accelerated Share Repurchase Program; MED announced it has entered into an accelerated share repurchase agreement ("ASR") with JPMorgan Chase, National Association ("JPM"), to repurchase an aggregate of $100 million of the company's common stock. This equates to approximately 600,000 shares, at the closing price on May 31, 2022, and represents approximately 5% of the company's fully diluted outstanding stock.
- Raytheon Technologies Corporation’s (RTX) Collins Aerospace selected to outfit the next generation of space explorers; RTX said its Collins Aerospace business was selected to produce NASA's next-generation spacesuit, as the agency pushes to replace decades-old hardware.
June 3, 2022
- Bristol Myers Squibb (BMY) to Acquire Turning Point Therapeutics; BMY and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) announced a definitive merger agreement under which Bristol Myers Squibb will acquire Turning Point Therapeutics for $76.00 per share. The transaction was unanimously approved by both the Bristol Myers Squibb and Turning Point Therapeutics Boards of Directors and is anticipated to close during the third quarter of 2022.
Articles that caught my attention:
- Undervalued Dividend Growth Stock of the Week: United Parcel Service (UPS) by Jason Fieber, Mr. Free at 33, at Daily Trade Alert
- Pass On Cisco Despite Its Attractive Valuation by Financial Freedom Is A Journey
- Best Canadian Renewable Energy Stocks – My top 5 by Bob at Tawcan
- What to do with a lump sum of money by Mark at My Own Advisor
- Manulife: A Quality 5.4% Yield by Trapping Value at Seeking Alpha
- These 5 Dividend Growth Stocks Are Down More Than 20% by Jason Fieber, Mr. Free at 33, at Daily Trade Alert
- Is Lowe's Stock A Buy Or Sell After Recent Earnings? A 31% Dividend Hike And A P/E Barely Above Great Recession Levels by Chuck Walston at Seeking Alpha
- The Dividend Aristocrats Ranked By Quality Scores by FerdiS at Seeking Alpha
- Home Depot (HD) vs. Lowe’s (LOW)…Which is the Better Stock to Buy?! by Bert at Dividend Diplomats
- VF Corporation (VFC): Undervalued Dividend Aristocrat by Dividend Power
- Ares Capital Stock: 2 Reasons A Dividend Cut Could Be Coming by High Yield Investor at Seeking Alpha
- Apple Inc. (AAPL) Dividend Stock Analysis by D4L at Dividend Growth Stocks
- Dividend Stock Watch List: Lanny’s June 2022 Edition by Lanny at Dividend Diplomats
- Hormel – Pass on This Dividend King by Financial Freedom Is A Journey
- Altria: Stellar Dividend Yield by Dividend Power at Seeking Alpha
- 10 Dividend Growth Stocks For June 2022 by FerdiS at Seeking Alpha
- Mastercard Vs. Visa: One Is The Better Bear Market Buy by Dividend Sensei at Seeking Alpha
Thanks for stopping by, have a nice next week!
No comments:
Post a Comment